Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants.

Jayasumana C, Orantes C, Herrera R, Almaguer M, Lopez L, Silva LC, Ordunez P, Siribaddana S, Gunatilake S, De Broe ME.

Nephrol Dial Transplant. 2017 Feb 1;32(2):234-241. doi: 10.1093/ndt/gfw346. Review.

PMID:
28186530
2.

Reverse osmosis plant maintenance and efficacy in chronic kidney disease endemic region in Sri Lanka.

Jayasumana C, Ranasinghe O, Ranasinghe S, Siriwardhana I, Gunatilake S, Siribaddana S.

Environ Health Prev Med. 2016 Nov;21(6):591-596. Epub 2016 Oct 15.

3.

Simultaneous exposure to multiple heavy metals and glyphosate may contribute to Sri Lankan agricultural nephropathy.

Jayasumana C, Gunatilake S, Siribaddana S.

BMC Nephrol. 2015 Jul 11;16:103. doi: 10.1186/s12882-015-0109-2.

4.

Phosphate fertilizer is a main source of arsenic in areas affected with chronic kidney disease of unknown etiology in Sri Lanka.

Jayasumana C, Fonseka S, Fernando A, Jayalath K, Amarasinghe M, Siribaddana S, Gunatilake S, Paranagama P.

Springerplus. 2015 Feb 24;4:90. doi: 10.1186/s40064-015-0868-z. eCollection 2015.

5.

Drinking well water and occupational exposure to Herbicides is associated with chronic kidney disease, in Padavi-Sripura, Sri Lanka.

Jayasumana C, Paranagama P, Agampodi S, Wijewardane C, Gunatilake S, Siribaddana S.

Environ Health. 2015 Jan 18;14:6. doi: 10.1186/1476-069X-14-6.

6.

Glyphosate, hard water and nephrotoxic metals: are they the culprits behind the epidemic of chronic kidney disease of unknown etiology in Sri Lanka?

Jayasumana C, Gunatilake S, Senanayake P.

Int J Environ Res Public Health. 2014 Feb 20;11(2):2125-47. doi: 10.3390/ijerph110202125.

7.

The Sri Lanka tsunami experience.

Yamada S, Gunatilake RP, Roytman TM, Gunatilake S, Fernando T, Fernando L.

Disaster Manag Response. 2006 Apr-Jun;4(2):38-48.

PMID:
16580983
8.

Atypical antipsychotic drugs, diabetes and ethnicity.

Ananth J, Kolli S, Gunatilake S, Brown S.

Expert Opin Drug Saf. 2005 Nov;4(6):1111-24. Review.

PMID:
16255668
9.

Atypical antipsychotic induced weight gain: pathophysiology and management.

Ananth J, Venkatesh R, Burgoyne K, Gadasalli R, Binford R, Gunatilake S.

Ann Clin Psychiatry. 2004 Apr-Jun;16(2):75-85. Review.

PMID:
15328901
10.

Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment.

Ananth J, Aduri K, Parameswaran S, Gunatilake S.

Acta Neuropsychiatr. 2004 Aug;16(4):219-28. doi: 10.1111/j.0924-2708.2004.00085.x.

PMID:
26984310
11.

Neuroleptic malignant syndrome and atypical antipsychotic drugs.

Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T.

J Clin Psychiatry. 2004 Apr;65(4):464-70.

PMID:
15119907
12.

Pharmacotherapy for refractory schizophrenia patients.

Ananth J, Ananth K, Burgoyne K, Sidhom T, Gunatilake S.

Expert Rev Neurother. 2003 May;3(3):387-401. doi: 10.1586/14737175.3.3.387.

PMID:
19810906
13.

Weight gain associated with atypical antipsychotic drugs: mechanisms and management.

Anath J, Venkatesh R, Burgoyne K, Augustines D, Corpuz V, Gunatilake S.

Expert Rev Neurother. 2003 Jan;3(1):59-68. doi: 10.1586/14737175.3.1.59.

PMID:
19810848
14.

Atypical antipsychotic drug use and diabetes.

Ananth J, Venkatesh R, Burgoyne K, Gunatilake S.

Psychother Psychosom. 2002 Sep-Oct;71(5):244-54.

PMID:
12207104

Supplemental Content

Loading ...
Support Center